Neimeth International Pharmaceuticals Plc (NGX:NEIMETH)

Nigeria flag Nigeria · Delayed Price · Currency is NGN
7.00
-0.05 (-0.71%)
At close: Aug 1, 2025
-0.71%
Market Cap29.91B
Revenue (ttm)5.04B
Net Income (ttm)-847.23M
Shares Out4.27B
EPS (ttm)-0.20
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume3,196,952
Average Volume5,684,179
Open7.00
Previous Close7.05
Day's Range7.00 - 7.20
52-Week Range1.76 - 10.42
Beta0.39
RSI50.67
Earnings DateJul 30, 2025

About NGX:NEIMETH

Neimeth International Pharmaceuticals Plc manufactures and markets pharmaceutical and animal health products in Nigeria and Ghana. It provides health care, ethical, and veterinary related products; and poultry and animal range of anthelmintic products, as well as production enhancing medicaments. The company was formerly known as Pfizer Inc. and changed its name to Neimeth International Pharmaceuticals Plc. In 1997. Neimeth International Pharmaceuticals Plc was incorporated in 1957 and is based in Lagos, Nigeria. [Read more]

Industry Pharmaceutical Preparations
Founded 1957
Employees 196
Stock Exchange Nigerian Stock Exchange
Ticker Symbol NEIMETH
Full Company Profile

Financial Performance

In 2024, NGX:NEIMETH's revenue was 4.49 billion, an increase of 102.98% compared to the previous year's 2.21 billion. Losses were -885.33 million, -50.75% less than in 2023.

Financial Statements

News

There is no news available yet.